vs
Side-by-side financial comparison of AVANOS MEDICAL, INC. (AVNS) and SHENANDOAH TELECOMMUNICATIONS CO (SHEN). Click either name above to swap in a different company.
AVANOS MEDICAL, INC. is the larger business by last-quarter revenue ($180.9M vs $91.6M, roughly 2.0× SHENANDOAH TELECOMMUNICATIONS CO). AVANOS MEDICAL, INC. runs the higher net margin — -0.7% vs -5.9%, a 5.1% gap on every dollar of revenue. On growth, SHENANDOAH TELECOMMUNICATIONS CO posted the faster year-over-year revenue change (7.2% vs 0.7%). AVANOS MEDICAL, INC. produced more free cash flow last quarter ($21.3M vs $-78.6M). Over the past eight quarters, SHENANDOAH TELECOMMUNICATIONS CO's revenue compounded faster (15.0% CAGR vs 4.4%).
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
Shenandoah Telecommunications Co is a U.S. regional telecom provider offering broadband internet, wireless voice/data services, digital cable TV, and fiber-optic solutions. It serves residential, small business and enterprise clients across Mid-Atlantic states, focusing on underserved rural and suburban markets in Virginia, West Virginia, Maryland and Pennsylvania.
AVNS vs SHEN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $180.9M | $91.6M |
| Net Profit | $-1.3M | $-5.4M |
| Gross Margin | 47.5% | — |
| Operating Margin | 1.4% | -1.0% |
| Net Margin | -0.7% | -5.9% |
| Revenue YoY | 0.7% | 7.2% |
| Net Profit YoY | 99.7% | -95.8% |
| EPS (diluted) | $-0.02 | $-0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $180.9M | $91.6M | ||
| Q3 25 | $177.8M | $89.8M | ||
| Q2 25 | $175.0M | $88.6M | ||
| Q1 25 | $167.5M | $87.9M | ||
| Q4 24 | $179.6M | $85.4M | ||
| Q3 24 | $170.4M | $87.6M | ||
| Q2 24 | $171.7M | $85.8M | ||
| Q1 24 | $166.1M | $69.2M |
| Q4 25 | $-1.3M | $-5.4M | ||
| Q3 25 | $-1.4M | $-9.4M | ||
| Q2 25 | $-76.8M | $-9.0M | ||
| Q1 25 | $6.6M | $-9.1M | ||
| Q4 24 | $-397.3M | $-2.7M | ||
| Q3 24 | $4.3M | $-5.3M | ||
| Q2 24 | $1.8M | $-12.9M | ||
| Q1 24 | $-900.0K | $214.7M |
| Q4 25 | 47.5% | — | ||
| Q3 25 | 48.4% | — | ||
| Q2 25 | 52.6% | — | ||
| Q1 25 | 53.6% | — | ||
| Q4 24 | 54.6% | — | ||
| Q3 24 | 54.5% | — | ||
| Q2 24 | 55.7% | — | ||
| Q1 24 | 57.1% | — |
| Q4 25 | 1.4% | -1.0% | ||
| Q3 25 | 0.1% | -8.0% | ||
| Q2 25 | -42.6% | -10.3% | ||
| Q1 25 | 6.1% | -6.9% | ||
| Q4 24 | -233.0% | -6.7% | ||
| Q3 24 | 7.0% | -4.8% | ||
| Q2 24 | 3.7% | -18.5% | ||
| Q1 24 | 2.4% | -4.0% |
| Q4 25 | -0.7% | -5.9% | ||
| Q3 25 | -0.8% | -10.5% | ||
| Q2 25 | -43.9% | -10.2% | ||
| Q1 25 | 3.9% | -10.4% | ||
| Q4 24 | -221.2% | -3.2% | ||
| Q3 24 | 2.5% | -6.0% | ||
| Q2 24 | 1.0% | -15.0% | ||
| Q1 24 | -0.5% | 310.0% |
| Q4 25 | $-0.02 | $-0.13 | ||
| Q3 25 | $-0.03 | $-0.20 | ||
| Q2 25 | $-1.66 | $-0.19 | ||
| Q1 25 | $0.14 | $-0.19 | ||
| Q4 24 | $-8.64 | $-0.34 | ||
| Q3 24 | $0.09 | $-0.13 | ||
| Q2 24 | $0.04 | $-0.24 | ||
| Q1 24 | $-0.02 | $4.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.8M | $27.3M |
| Total DebtLower is stronger | $90.3M | $642.4M |
| Stockholders' EquityBook value | $778.2M | $880.8M |
| Total Assets | $1.1B | $1.9B |
| Debt / EquityLower = less leverage | 0.12× | 0.73× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.8M | $27.3M | ||
| Q3 25 | $70.5M | $22.6M | ||
| Q2 25 | $90.3M | $29.1M | ||
| Q1 25 | $97.0M | $87.5M | ||
| Q4 24 | $107.7M | $46.3M | ||
| Q3 24 | $89.0M | $43.1M | ||
| Q2 24 | $92.2M | $43.8M | ||
| Q1 24 | $75.8M | $389.7M |
| Q4 25 | $90.3M | $642.4M | ||
| Q3 25 | $93.4M | $535.4M | ||
| Q2 25 | $95.7M | $513.1M | ||
| Q1 25 | $98.0M | $515.8M | ||
| Q4 24 | $125.3M | $418.0M | ||
| Q3 24 | $152.6M | $345.2M | ||
| Q2 24 | $164.9M | $297.4M | ||
| Q1 24 | $167.2M | $298.7M |
| Q4 25 | $778.2M | $880.8M | ||
| Q3 25 | $778.0M | $892.7M | ||
| Q2 25 | $776.3M | $902.0M | ||
| Q1 25 | $839.4M | $910.5M | ||
| Q4 24 | $828.5M | $918.6M | ||
| Q3 24 | $1.2B | $925.4M | ||
| Q2 24 | $1.2B | $933.1M | ||
| Q1 24 | $1.2B | $871.6M |
| Q4 25 | $1.1B | $1.9B | ||
| Q3 25 | $1.1B | $1.9B | ||
| Q2 25 | $1.0B | $1.8B | ||
| Q1 25 | $1.1B | $1.8B | ||
| Q4 24 | $1.2B | $1.7B | ||
| Q3 24 | $1.7B | $1.7B | ||
| Q2 24 | $1.7B | $1.7B | ||
| Q1 24 | $1.7B | $1.4B |
| Q4 25 | 0.12× | 0.73× | ||
| Q3 25 | 0.12× | 0.60× | ||
| Q2 25 | 0.12× | 0.57× | ||
| Q1 25 | 0.12× | 0.57× | ||
| Q4 24 | 0.15× | 0.46× | ||
| Q3 24 | 0.12× | 0.37× | ||
| Q2 24 | 0.13× | 0.32× | ||
| Q1 24 | 0.14× | 0.34× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.2M | $28.8M |
| Free Cash FlowOCF − Capex | $21.3M | $-78.6M |
| FCF MarginFCF / Revenue | 11.8% | -85.8% |
| Capex IntensityCapex / Revenue | 3.8% | 117.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | $-257.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.2M | $28.8M | ||
| Q3 25 | $14.0M | $30.7M | ||
| Q2 25 | $6.8M | $20.9M | ||
| Q1 25 | $25.7M | $20.5M | ||
| Q4 24 | $57.9M | $20.6M | ||
| Q3 24 | $23.0M | $24.3M | ||
| Q2 24 | $27.8M | $2.5M | ||
| Q1 24 | $-8.0M | $15.2M |
| Q4 25 | $21.3M | $-78.6M | ||
| Q3 25 | $7.0M | $-51.4M | ||
| Q2 25 | $-4.2M | $-65.3M | ||
| Q1 25 | $19.0M | $-62.7M | ||
| Q4 24 | $53.1M | $-72.0M | ||
| Q3 24 | $20.0M | $-51.3M | ||
| Q2 24 | $21.9M | $-78.3M | ||
| Q1 24 | $-12.1M | $-54.9M |
| Q4 25 | 11.8% | -85.8% | ||
| Q3 25 | 3.9% | -57.2% | ||
| Q2 25 | -2.4% | -73.7% | ||
| Q1 25 | 11.3% | -71.3% | ||
| Q4 24 | 29.6% | -84.3% | ||
| Q3 24 | 11.7% | -58.5% | ||
| Q2 24 | 12.8% | -91.3% | ||
| Q1 24 | -7.3% | -79.3% |
| Q4 25 | 3.8% | 117.2% | ||
| Q3 25 | 3.9% | 91.4% | ||
| Q2 25 | 6.3% | 97.3% | ||
| Q1 25 | 4.0% | 94.7% | ||
| Q4 24 | 2.7% | 108.4% | ||
| Q3 24 | 1.8% | 86.2% | ||
| Q2 24 | 3.4% | 94.2% | ||
| Q1 24 | 2.5% | 101.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.89× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.35× | — | ||
| Q2 24 | 15.44× | — | ||
| Q1 24 | — | 0.07× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
SHEN
| Residential And SMB Incumbent Broadband | $41.5M | 45% |
| Residential And SMB Glo Fiber Expansion Markets | $23.0M | 25% |
| Commercial Fiber | $20.3M | 22% |
| RLEC Other | $6.8M | 7% |
